These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 4153124)

  • 1. The influence of cytochrome P-450 induction on the metabolic formation of 455-NM complexes from amphetamines.
    Franklin MR
    Drug Metab Dispos; 1974; 2(3):321-6. PubMed ID: 4153124
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of enzyme inducers on substrate specificity of the cytochrome P-450's.
    Conney AH; Lu AY; Levin W; Somogyi A; West S; Jacobson M; Ryan D; Kuntzman R
    Drug Metab Dispos; 1973; 1(1):199-210. PubMed ID: 4129867
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene.
    Burke MD; Mayer RT
    Drug Metab Dispos; 1974; 2(6):583-8. PubMed ID: 4155680
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction of liver microsomal drug metabolism in newly-hatched chicks.
    Jondorf WR; MacIntyre DE; Powis G
    Br J Pharmacol; 1973 Mar; 47(3):624P-625P. PubMed ID: 4147194
    [No Abstract]   [Full Text] [Related]  

  • 5. Some selected studies on hepatic microsomal drug-metabolizing enzymes--environment interactions.
    Fouts JR
    Drug Metab Dispos; 1973; 1(1):380-5. PubMed ID: 4149408
    [No Abstract]   [Full Text] [Related]  

  • 6. On the mechanism of hydroxylation reactions catalyzed by cytochrome P-450.
    Coon MJ; Strobel HW; Boyer RF
    Drug Metab Dispos; 1973; 1(1):92-7. PubMed ID: 4149427
    [No Abstract]   [Full Text] [Related]  

  • 7. Species differences and drug metabolism.
    Flynn EJ; Lynch M; Zannoni VG
    Biochem Pharmacol; 1972 Oct; 21(19):2577-90. PubMed ID: 4145289
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study on drug hydroxylation and glucuronidation in liver microsomes of phenobarbital and 3-methylcholanthrene treated rats.
    Vainio H; Hänninen O
    Acta Pharmacol Toxicol (Copenh); 1974 Jul; 35(1):65-75. PubMed ID: 4210060
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between NADH and NADPH oxidation during drug metabolism.
    Sasame HA; Mitchell JR; Thorgeirsson S; Gillette JR
    Drug Metab Dispos; 1973; 1(1):150-5. PubMed ID: 4129866
    [No Abstract]   [Full Text] [Related]  

  • 11. NADPH-cytochrome c reductase and its role in microsomal cytochrome P-450-dependent reactions.
    Masters BS; Nelson EB; Schacter BA; Baron J; Isaacson EL
    Drug Metab Dispos; 1973; 1(1):121-8. PubMed ID: 4129865
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the effects of methylmercury on ethylmorphine N-demethylase and aniline hydroxylase activities and on the conversion of cytochrome P-450 to cytochrome P-420.
    Alvares AP; Cohn J; Kappas A
    Drug Metab Dispos; 1974; 2(3):259-66. PubMed ID: 4153087
    [No Abstract]   [Full Text] [Related]  

  • 13. The p-hydroxylation of amphetamine and phentermine by rat liver microsomes.
    Cho AK; Hodshon BJ; Lindeke B; Jonsson J
    Xenobiotica; 1975 Sep; 5(9):531-8. PubMed ID: 242122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat.
    Law MY; Slawson MH; Moody DE
    Drug Metab Dispos; 2000 Mar; 28(3):348-53. PubMed ID: 10681381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against participation of cytochrome b5 in the hepatic microsomal mixed-function oxidase reaction.
    Jansson I; Schenkman JB
    Mol Pharmacol; 1973 Nov; 9(6):840-5. PubMed ID: 4148656
    [No Abstract]   [Full Text] [Related]  

  • 16. The formation of cytochrome P-450-metabolic intermediate complexes in microsomal fractions from extrahepatic tissues of the rabbit.
    Buening MK; Franklin MR
    Drug Metab Dispos; 1976; 4(6):556-61. PubMed ID: 11977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-dependent differences in drug metabolism in the rat. 3. Temporal changes in type I binding and NADPH-cytochrome, P-450 reductase during sexual maturation.
    Cohen GM; Mannering GJ
    Drug Metab Dispos; 1974; 2(3):285-92. PubMed ID: 4153061
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inactivation of microsomal proteins by lysosomes (author's transl)].
    Betz H; Gratzl M; Remmer H
    Hoppe Seylers Z Physiol Chem; 1973 May; 354(5):567-75. PubMed ID: 4154275
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the molecular function of cytochrome P-450 during drug metabolism.
    Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
    Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.